Summary

Patient engagement is a partnership between a patient and their healthcare provider team where both sides share information and search for the best treatment options. It is opposed to the conventional rigid system where the doctor prescribes one treatment course, and the patient feels free to either accept or ignore it instead of attempting to discuss other options. In addition, using technology, doctors can reach their patients anytime and anywhere, foresee and mitigate deterioration in conditions of patients, and provide helpful information at the right time. These goals can be achieved with the help of patient engagement software — an application or a set of interconnected systems designed to facilitate communication between patients and healthcare providers, offer educational resources, and otherwise manage the patient-doctor relationship.

Growth in emphasis on automation trends across regions is one of the major driving factors for the patient engagement solution market. It provides many beneficial aspects such as registering new patients and managing their medical history online, scheduling and rescheduling appointments, and others. It also offers to send automatic appointment reminders either via text or voice messages. Thus, there is a growth in demand for real-time identification, monitoring, and response capabilities provided by patient engagement solutions. These factors are further expected to propel the growth of the global patient engagement solution market.
Furthermore, the market is profoundly influenced by considerable expenses related to patient engagement solutions and services. Primarily, these expenses can serve as a deterrent for smaller and medium-sized enterprises (SMEs) with constrained budgets. SMEs may perceive patient engagement solutions as a financial burden, leading to insufficient investment in healthcare measures. In addition, even larger organizations may exhibit hesitation in allocating substantial resources to patient engagement solutions, particularly when faced with competing budgetary demands.

The notable factors positively affecting the patient engagement solutions market include rise in awareness regarding mobile health among people and growing emphasis on electronic health record (HER) reports. However, extensive investments required for healthcare infrastructure and high complexity associated with the integration of advanced solutions with existing healthcare infrastructure components often hinder market growth. However, rise in significance of cloud computing technologies to deliver remote patient monitoring and assistance services offers lucrative market opportunities for the market players.
The patient engagement solution market is segmented on the basis of component, deployment mode, functionality, end user, and region. On the basis of component, the market is segmented into hardware, software, and service. On the basis of deployment mode, the market is bifurcated into on-premise and cloud. On the basis of functionality, the market is segmented into communication, health tracking and insight, billing and payments, administrative, and others. On the basis of end user, the market is segmented into providers, payers and patients. On the basis of region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The market players operating in the global patient engagement solutions market. This report further outlines the current trends and key areas of investment. In addition, it includes Porter’s five forces analysis to understand the competitive scenario of the industry and role of each stakeholder. The report features the strategies adopted by key market players to maintain their foothold in the market. Furthermore, it highlights the competitive landscape of key market players to increase their market share and sustain intense competition in the industry. The key players operating in the market include Aetna Inc., Allscripts Healthcare Solutions, Inc. (Veradigm LLC), Athenahealth, Oracle Corporation, EPIC Systems Corporation, GetWellNetwork, Inc., IBM Corporation, IQVIA Inc., Lumeon Inc. and McKesson Corporation.

KEY BENEFITS FOR STAKEHOLDERS
●The study provides an in-depth analysis of the patient engagement solutions market forecast along with the current and future trends to explain the imminent investment pockets.
●Information about key drivers, restraints, and opportunities and their impact analysis on patient engagement solutions market trends is provided in the report.
●The Porter’s five forces analysis illustrates the potency of the buyers and suppliers operating in the industry.
●The quantitative analysis of the patient engagement solutions market from 2022 to 2032 is provided to determine the market potential.

Additional benefits you will get with this purchase are:
● Quarterly Update and* (only available with a corporate license, on listed price)
● 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
● Free Upcoming Version on the Purchase of Five and Enterprise User License.
● 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
● 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
● Free data Pack on the Five and Enterprise User License. (Excel version of the report)
● Free Updated report if the report is 6-12 months old or older.
● 24-hour priority response*
● Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)
● Investment Opportunities
● Market share analysis of players by products/segments
● Regulatory Guidelines
● Additional company profiles with specific to client's interest
● Additional country or region analysis- market size and forecast
● Market share analysis of players at global/region/country level
● SWOT Analysis
Key Market Segments
By End User
● Providers
● Payers
● Patients
By Component
● Hardware
● Software
● Services
By Deployment Mode
● On-premise
● Cloud
By Functionality
● Communication
● Health Tracking and Insights
● Biling and Payments
● Administrative
● Others
By Region
● North America
○ U.S.
○ Canada
● Europe
○ UK
○ Germany
○ France
○ Italy
○ Spain
○ Rest of Europe
● Asia-Pacific
○ China
○ Japan
○ India
○ Australia
○ South Korea
○ Rest of Asia-Pacific
● LAMEA
○ Latin America
○ Middle East
○ Africa
● Key Market Players
○ Aetna Inc.
○ Athenahealth
○ EPIC Systems Corporation
○ IBM Corporation
○ IQVIA Inc.
○ Lumeon Inc.
○ Allscripts Healthcare Solutions, Inc. (Veradigm LLC)
○ Oracle Corporation
○ GetWellNetwork, Inc.
○ McKesson Corporation.

ページTOPに戻る

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter’s five forces analysis
3.3.1. Low threat of new entrants
3.3.2. Low threat of substitutes
3.3.3. Low intensity of rivalry
3.3.4. Low bargaining power of buyers
3.3.5. Low bargaining power of suppliers
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Rise in awareness regarding mobile health among people
3.4.1.2. Growth in emphasis on electronic health record (EHR) reports
3.4.2. Restraints
3.4.2.1. Extensive investments required for healthcare infrastructure
3.4.2.2. High complexity associated with the integration of advanced solutions with existing healthcare infrastructure components
3.4.3. Opportunities
3.4.3.1. Rise in significance of cloud computing technologies to deliver remote patient monitoring and assistance services
CHAPTER 4: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT
4.1. Overview
4.1.1. Market size and forecast
4.2. Hardware
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.3. Software
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
4.4. Services
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market share analysis by country
CHAPTER 5: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DEPLOYMENT MODE
5.1. Overview
5.1.1. Market size and forecast
5.2. On-premise
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Cloud
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
CHAPTER 6: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY
6.1. Overview
6.1.1. Market size and forecast
6.2. Communication
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market share analysis by country
6.3. Health Tracking and Insights
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market share analysis by country
6.4. Biling and Payments
6.4.1. Key market trends, growth factors and opportunities
6.4.2. Market size and forecast, by region
6.4.3. Market share analysis by country
6.5. Administrative
6.5.1. Key market trends, growth factors and opportunities
6.5.2. Market size and forecast, by region
6.5.3. Market share analysis by country
6.6. Others
6.6.1. Key market trends, growth factors and opportunities
6.6.2. Market size and forecast, by region
6.6.3. Market share analysis by country
CHAPTER 7: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER
7.1. Overview
7.1.1. Market size and forecast
7.2. Providers
7.2.1. Key market trends, growth factors and opportunities
7.2.2. Market size and forecast, by region
7.2.3. Market share analysis by country
7.3. Payers
7.3.1. Key market trends, growth factors and opportunities
7.3.2. Market size and forecast, by region
7.3.3. Market share analysis by country
7.4. Patients
7.4.1. Key market trends, growth factors and opportunities
7.4.2. Market size and forecast, by region
7.4.3. Market share analysis by country
CHAPTER 8: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY REGION
8.1. Overview
8.1.1. Market size and forecast By Region
8.2. North America
8.2.1. Key market trends, growth factors and opportunities
8.2.2. Market size and forecast, by Component
8.2.3. Market size and forecast, by Deployment Mode
8.2.4. Market size and forecast, by Functionality
8.2.5. Market size and forecast, by End User
8.2.6. Market size and forecast, by country
8.2.6.1. U.S.
8.2.6.1.1. Market size and forecast, by Component
8.2.6.1.2. Market size and forecast, by Deployment Mode
8.2.6.1.3. Market size and forecast, by Functionality
8.2.6.1.4. Market size and forecast, by End User
8.2.6.2. Canada
8.2.6.2.1. Market size and forecast, by Component
8.2.6.2.2. Market size and forecast, by Deployment Mode
8.2.6.2.3. Market size and forecast, by Functionality
8.2.6.2.4. Market size and forecast, by End User
8.3. Europe
8.3.1. Key market trends, growth factors and opportunities
8.3.2. Market size and forecast, by Component
8.3.3. Market size and forecast, by Deployment Mode
8.3.4. Market size and forecast, by Functionality
8.3.5. Market size and forecast, by End User
8.3.6. Market size and forecast, by country
8.3.6.1. UK
8.3.6.1.1. Market size and forecast, by Component
8.3.6.1.2. Market size and forecast, by Deployment Mode
8.3.6.1.3. Market size and forecast, by Functionality
8.3.6.1.4. Market size and forecast, by End User
8.3.6.2. Germany
8.3.6.2.1. Market size and forecast, by Component
8.3.6.2.2. Market size and forecast, by Deployment Mode
8.3.6.2.3. Market size and forecast, by Functionality
8.3.6.2.4. Market size and forecast, by End User
8.3.6.3. France
8.3.6.3.1. Market size and forecast, by Component
8.3.6.3.2. Market size and forecast, by Deployment Mode
8.3.6.3.3. Market size and forecast, by Functionality
8.3.6.3.4. Market size and forecast, by End User
8.3.6.4. Italy
8.3.6.4.1. Market size and forecast, by Component
8.3.6.4.2. Market size and forecast, by Deployment Mode
8.3.6.4.3. Market size and forecast, by Functionality
8.3.6.4.4. Market size and forecast, by End User
8.3.6.5. Spain
8.3.6.5.1. Market size and forecast, by Component
8.3.6.5.2. Market size and forecast, by Deployment Mode
8.3.6.5.3. Market size and forecast, by Functionality
8.3.6.5.4. Market size and forecast, by End User
8.3.6.6. Rest of Europe
8.3.6.6.1. Market size and forecast, by Component
8.3.6.6.2. Market size and forecast, by Deployment Mode
8.3.6.6.3. Market size and forecast, by Functionality
8.3.6.6.4. Market size and forecast, by End User
8.4. Asia-Pacific
8.4.1. Key market trends, growth factors and opportunities
8.4.2. Market size and forecast, by Component
8.4.3. Market size and forecast, by Deployment Mode
8.4.4. Market size and forecast, by Functionality
8.4.5. Market size and forecast, by End User
8.4.6. Market size and forecast, by country
8.4.6.1. China
8.4.6.1.1. Market size and forecast, by Component
8.4.6.1.2. Market size and forecast, by Deployment Mode
8.4.6.1.3. Market size and forecast, by Functionality
8.4.6.1.4. Market size and forecast, by End User
8.4.6.2. Japan
8.4.6.2.1. Market size and forecast, by Component
8.4.6.2.2. Market size and forecast, by Deployment Mode
8.4.6.2.3. Market size and forecast, by Functionality
8.4.6.2.4. Market size and forecast, by End User
8.4.6.3. India
8.4.6.3.1. Market size and forecast, by Component
8.4.6.3.2. Market size and forecast, by Deployment Mode
8.4.6.3.3. Market size and forecast, by Functionality
8.4.6.3.4. Market size and forecast, by End User
8.4.6.4. Australia
8.4.6.4.1. Market size and forecast, by Component
8.4.6.4.2. Market size and forecast, by Deployment Mode
8.4.6.4.3. Market size and forecast, by Functionality
8.4.6.4.4. Market size and forecast, by End User
8.4.6.5. South Korea
8.4.6.5.1. Market size and forecast, by Component
8.4.6.5.2. Market size and forecast, by Deployment Mode
8.4.6.5.3. Market size and forecast, by Functionality
8.4.6.5.4. Market size and forecast, by End User
8.4.6.6. Rest of Asia-Pacific
8.4.6.6.1. Market size and forecast, by Component
8.4.6.6.2. Market size and forecast, by Deployment Mode
8.4.6.6.3. Market size and forecast, by Functionality
8.4.6.6.4. Market size and forecast, by End User
8.5. LAMEA
8.5.1. Key market trends, growth factors and opportunities
8.5.2. Market size and forecast, by Component
8.5.3. Market size and forecast, by Deployment Mode
8.5.4. Market size and forecast, by Functionality
8.5.5. Market size and forecast, by End User
8.5.6. Market size and forecast, by country
8.5.6.1. Latin America
8.5.6.1.1. Market size and forecast, by Component
8.5.6.1.2. Market size and forecast, by Deployment Mode
8.5.6.1.3. Market size and forecast, by Functionality
8.5.6.1.4. Market size and forecast, by End User
8.5.6.2. Middle East
8.5.6.2.1. Market size and forecast, by Component
8.5.6.2.2. Market size and forecast, by Deployment Mode
8.5.6.2.3. Market size and forecast, by Functionality
8.5.6.2.4. Market size and forecast, by End User
8.5.6.3. Africa
8.5.6.3.1. Market size and forecast, by Component
8.5.6.3.2. Market size and forecast, by Deployment Mode
8.5.6.3.3. Market size and forecast, by Functionality
8.5.6.3.4. Market size and forecast, by End User
CHAPTER 9: COMPETITIVE LANDSCAPE
9.1. Introduction
9.2. Top winning strategies
9.3. Product mapping of top 10 player
9.4. Competitive dashboard
9.5. Competitive heatmap
9.6. Top player positioning, 2022
CHAPTER 10: COMPANY PROFILES
10.1. Aetna Inc.
10.1.1. Company overview
10.1.2. Key executives
10.1.3. Company snapshot
10.1.4. Operating business segments
10.1.5. Product portfolio
10.1.6. Business performance
10.1.7. Key strategic moves and developments
10.2. Allscripts Healthcare Solutions, Inc. (Veradigm LLC)
10.2.1. Company overview
10.2.2. Key executives
10.2.3. Company snapshot
10.2.4. Operating business segments
10.2.5. Product portfolio
10.2.6. Business performance
10.3. Athenahealth
10.3.1. Company overview
10.3.2. Key executives
10.3.3. Company snapshot
10.3.4. Operating business segments
10.3.5. Product portfolio
10.3.6. Key strategic moves and developments
10.4. Oracle Corporation
10.4.1. Company overview
10.4.2. Key executives
10.4.3. Company snapshot
10.4.4. Operating business segments
10.4.5. Product portfolio
10.4.6. Business performance
10.4.7. Key strategic moves and developments
10.5. EPIC Systems Corporation
10.5.1. Company overview
10.5.2. Key executives
10.5.3. Company snapshot
10.5.4. Operating business segments
10.5.5. Product portfolio
10.5.6. Key strategic moves and developments
10.6. GetWellNetwork, Inc.
10.6.1. Company overview
10.6.2. Key executives
10.6.3. Company snapshot
10.6.4. Operating business segments
10.6.5. Product portfolio
10.6.6. Key strategic moves and developments
10.7. IBM Corporation
10.7.1. Company overview
10.7.2. Key executives
10.7.3. Company snapshot
10.7.4. Operating business segments
10.7.5. Product portfolio
10.7.6. Business performance
10.8. IQVIA Inc.
10.8.1. Company overview
10.8.2. Key executives
10.8.3. Company snapshot
10.8.4. Operating business segments
10.8.5. Product portfolio
10.8.6. Business performance
10.8.7. Key strategic moves and developments
10.9. Lumeon Inc.
10.9.1. Company overview
10.9.2. Key executives
10.9.3. Company snapshot
10.9.4. Operating business segments
10.9.5. Product portfolio
10.10. McKesson Corporation.
10.10.1. Company overview
10.10.2. Key executives
10.10.3. Company snapshot
10.10.4. Operating business segments
10.10.5. Product portfolio
10.10.6. Business performance
10.10.7. Key strategic moves and developments